JP2025509917A5 - - Google Patents
Info
- Publication number
- JP2025509917A5 JP2025509917A5 JP2024556043A JP2024556043A JP2025509917A5 JP 2025509917 A5 JP2025509917 A5 JP 2025509917A5 JP 2024556043 A JP2024556043 A JP 2024556043A JP 2024556043 A JP2024556043 A JP 2024556043A JP 2025509917 A5 JP2025509917 A5 JP 2025509917A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrazine
- carboxamide
- indole
- amino
- methylpropyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263269879P | 2022-03-24 | 2022-03-24 | |
| US63/269,879 | 2022-03-24 | ||
| PCT/IB2023/052827 WO2023180964A1 (en) | 2022-03-24 | 2023-03-22 | Pyrazine amide derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025509917A JP2025509917A (ja) | 2025-04-11 |
| JP2025509917A5 true JP2025509917A5 (https=) | 2026-01-23 |
Family
ID=85979464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024556043A Pending JP2025509917A (ja) | 2022-03-24 | 2023-03-22 | ピラジンアミド誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250197376A1 (https=) |
| EP (1) | EP4499631A1 (https=) |
| JP (1) | JP2025509917A (https=) |
| CN (1) | CN118591538A (https=) |
| AU (1) | AU2023240513A1 (https=) |
| CA (2) | CA3181279A1 (https=) |
| CO (1) | CO2024010469A2 (https=) |
| DO (1) | DOP2024000149A (https=) |
| WO (1) | WO2023180964A1 (https=) |
| ZA (1) | ZA202405048B (https=) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009137081A2 (en) * | 2008-05-07 | 2009-11-12 | Massachusetts Institute Of Technology | Small molecule inhibitors of plasmodium falciparum dihydroorotate dehydrogenase |
| CN102089278A (zh) * | 2008-06-11 | 2011-06-08 | Irm责任有限公司 | 用于治疗疟疾的化合物和组合物 |
| ES2921576T3 (es) * | 2008-12-19 | 2022-08-29 | Vertex Pharma | Compuestos útiles como inhibidores de la quinasa ATR |
| US8962631B2 (en) | 2010-05-12 | 2015-02-24 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| LT2925757T (lt) * | 2012-11-19 | 2017-12-27 | Novartis Ag | Junginiai ir kompozicijos, skirti parazitinių ligų gydymui |
| WO2016089977A1 (en) * | 2014-12-03 | 2016-06-09 | Celgene Corporation | Substituted indazole compounds, compositions thereof, and methods of treatment therewith |
| CN110023312A (zh) * | 2016-10-13 | 2019-07-16 | 由卫生与公众服务部部长代表的美利坚合众国 | 阻止疟疾寄生虫传播的化合物和方法 |
| WO2018081863A1 (en) * | 2016-11-04 | 2018-05-11 | University Of Wollongong | 6-SUBSTITUTED DERIVATIVES OF HEXAMETHYLENE AMILORIDE AS INHIBITORS OF uPA AND USES THEREOF |
| EP3790878A1 (en) * | 2018-05-11 | 2021-03-17 | The United States of America, as represented by the Secretary, Department of Health and Human Services | Quinoline compounds and their preparation and use as antimalarial agents |
-
2022
- 2022-11-04 CA CA3181279A patent/CA3181279A1/en active Pending
-
2023
- 2023-03-22 CA CA3251003A patent/CA3251003A1/en active Pending
- 2023-03-22 CN CN202380018582.3A patent/CN118591538A/zh active Pending
- 2023-03-22 US US18/849,215 patent/US20250197376A1/en active Pending
- 2023-03-22 JP JP2024556043A patent/JP2025509917A/ja active Pending
- 2023-03-22 AU AU2023240513A patent/AU2023240513A1/en active Pending
- 2023-03-22 WO PCT/IB2023/052827 patent/WO2023180964A1/en not_active Ceased
- 2023-03-22 EP EP23715945.4A patent/EP4499631A1/en active Pending
-
2024
- 2024-06-27 ZA ZA2024/05048A patent/ZA202405048B/en unknown
- 2024-07-31 DO DO2024000149A patent/DOP2024000149A/es unknown
- 2024-07-31 CO CONC2024/0010469A patent/CO2024010469A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2763556T3 (es) | Antagonistas fluorados de integrina | |
| JP7515467B2 (ja) | Ｖａｐ－１の阻害剤 | |
| US10842792B2 (en) | Deuterated baricitinib | |
| US9790222B2 (en) | Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof | |
| CN114026067A (zh) | 用于治疗冠状病毒和小核糖核酸病毒感染的肽模拟物 | |
| US20210002295A1 (en) | Small molecule degraders that recruit dcaf15 | |
| SG178252A1 (en) | Dp2 antagonist and uses thereof | |
| US20180036416A1 (en) | Compounds and compositions for the treatment of ocular disorders | |
| JP7475055B2 (ja) | （ｓ）－３－アミノ－４－（ジフルオロメチレニル）シクロペンタ－１－エン－１－カルボン酸の合成法 | |
| JP2022062115A (ja) | ｓＧＣ刺激剤のリンプロドラッグ | |
| WO2021170811A1 (en) | Method of treating eye disease using trpv4 antagonists | |
| CN114174255A (zh) | 用于预防和治疗手术后认知功能障碍的化合物 | |
| US20120058085A1 (en) | Deuterium Modified Benzimidazoles | |
| WO2006049250A1 (ja) | 眼内移行性促進水性点眼剤 | |
| JP2025509917A5 (https=) | ||
| JP2020520891A (ja) | 眼障害の治療のための薬物及び組成物 | |
| US10537563B2 (en) | Methods for treating ocular disease using inhibitors of CSF-1R | |
| US9676790B2 (en) | Substituted thienotriazolodiazapines | |
| US20060040962A1 (en) | Pharmaceutical formulations | |
| US10118929B2 (en) | Nonanoic and decanoic acid derivatives and uses thereof | |
| JP6427843B2 (ja) | 眼疾患治療剤 | |
| WO2025223511A1 (zh) | 一类苯甲酰基甘氨酸衍生物及其制备方法和应用 | |
| EA045683B1 (ru) | ТВЕРДЫЕ ФОРМЫ СТИМУЛЯТОРА sGC |